MedPath

Folia Biotech, Inc.

🇨🇦Canada
Ownership
Private
Employees
-
Market Cap
-
Website
http://www.foliabiotech.com

Safety and Reactogenicity of a PAL Combined With Seasonal Flu Vaccine in Healthy Adults

Phase 1
Conditions
Flu
Interventions
Biological: TIV
Biological: PAL
First Posted Date
2014-07-14
Last Posted Date
2016-02-12
Lead Sponsor
Folia Biotech Inc.
Target Recruit Count
48
Registration Number
NCT02188810
Locations
🇨🇦

Canadian Center for Vaccinology, Halifax, Nova Scotia, Canada

© Copyright 2025. All Rights Reserved by MedPath